By Professor Kathy Petoumenos

Journal articles

Martinello M; Orkin C; Cooke G; Bhagani S; Gane E; Kulasegaram R; Shaw D; Tu E; Filep E; Petoumenos K; Marks P; Applegate T; Grebely J; Dore G; Nelson M; Matthews G, 2019, 'Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvir for six weeks among people with acute and recent HCV infection', JOURNAL OF HEPATOLOGY, 70, pp. E231 - E231, http://dx.doi.org/10.1016/S0618-8278(19)30432-3

Dore G; Feld J; Thompson A; Martinello M; Muir A; Agarwal K; Mullhaupt B; Wedemeyer H; Lacombe K; Matthews G; Schultz M; Mercade GE; Kho D; Filep E; Petoumenos K; Marks P; Tatsch F; dos Santos AGP; Gane E, 2019, 'Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir: the SMART-C study', JOURNAL OF HEPATOLOGY, 70, pp. E110 - E110, http://dx.doi.org/10.1016/S0618-8278(19)30196-3

Goddard SL; Templeton DJ; Petoumenos K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Poynten IM; Prestage G; Tong W; Carr A; Varma R, 2019, 'Association of anal symptoms with anal high grade squamous intraepithelial lesions (HSIL) among men who have sex with men: Baseline data from the study of the prevention of anal cancer (SPANC)', Cancer Epidemiology, 58, pp. 12 - 16, http://dx.doi.org/10.1016/j.canep.2018.10.009

Puhr R; Petoumenos K; Huang R; Templeton DJ; Woolley I; Bloch M; Russell D; Law MG; Cooper DA, 2019, 'Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study', HIV Medicine, 20, pp. 121 - 130, http://dx.doi.org/10.1111/hiv.12689

Shepherd L; Ryom L; Law M; Petoumenos K; Hatleberg CI; D'Arminio Monforte A; Sabin C; Bower M; Bonnet F; Reiss P; De Wit S; Pradier C; Weber R; El-Sadr W; Lundgren J; Mocroft A, 2019, 'Cessation of cigarette smoking and the impact on cancer incidence in human immunodeficiency virus-infected persons: The data collection on adverse events of anti-HIV drugs study', Clinical Infectious Diseases, 68, pp. 650 - 657, http://dx.doi.org/10.1093/cid/ciy508

Dharan NJ; Radovich T; Che S; Petoumenos K; Juneja P; Law M; Huang R; McManus H; Polizzotto MN; Guy R; Cronin P; Cooper DA; Gray RT; Law M; Han A, 2019, 'HIV treatment regimens and adherence to national guidelines in Australia: An analysis of dispensing data from the Australian pharmaceutical benefits scheme', BMC Public Health, 19, pp. 13, http://dx.doi.org/10.1186/s12889-018-6325-5

Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9

Hughes C; Puhr R; Ojaimi S; Petoumenos K; Bartlett AW; Templeton DJ; O'Connor CC; Gunathilake M; Woolley I, 2018, 'Human immunodeficiency virus-infected young people in Australia: data from the Australian HIV Observational Database', Internal Medicine Journal, 48, pp. 1447 - 1456, http://dx.doi.org/10.1111/imj.14040

Grebely J; Conway B; Cunningham EB; Fraser C; Moriggia A; Gane E; Stedman C; Cooper C; Castro E; Schmid P; Petoumenos K; Hajarizadeh B; Marks P; Erratt A; Dalgard O; Lacombe K; Feld JJ; Bruneau J; Daulouede JP; Powis J; Bruggmann P; Matthews GV; Kronborg I; Shaw D; Dunlop A; Hellard M; Applegate TL; Crawford S; Dore GJ, 2018, 'Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy', International Journal of Drug Policy, 62, pp. 94 - 103, http://dx.doi.org/10.1016/j.drugpo.2018.10.004

Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K, 2018, 'Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality', AIDS Research and Human Retroviruses, 34, pp. 936 - 941, http://dx.doi.org/10.1089/aid.2017.0284

Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD, 2018, 'RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency', Retrovirology, 15, pp. 67, http://dx.doi.org/10.1186/s12977-018-0451-0

Martinello M; Bhagani S; Gane E; Orkin C; Cooke G; Dore GJ; Petoumenos K; Applegate TL; Tu E; Marks P; Pagani N; Grebely J; Nelson M; Matthews GV, 2018, 'Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection', Journal of Viral Hepatitis, 25, pp. 1180 - 1188, http://dx.doi.org/10.1111/jvh.12917

Trevillyan JM; Wong G; Puls R; Petoumenos K; Emery S; Mellett NA; Mundra PA; Meikle PJ; Hoy JF, 2018, 'Changes in plasma lipidome following initiation of antiretroviral therapy', PLoS ONE, 13, pp. e0202944, http://dx.doi.org/10.1371/journal.pone.0202944

Cheung J; Puhr R; Petoumenos K; Cooper DA; Woolley I; Gunathilake M; Raymond N; Varma R; O'Connor CC; Gracey DM, 2018, 'Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database', Nephrology, 23, pp. 778 - 786, http://dx.doi.org/10.1111/nep.13100

Huang R; Petoumenos K; Gray RT; McManus H; Dharan N; Guy R; Cooper DA, 2018, 'National characteristics and trends in antiretroviral treatment in Australia can be accurately estimated using a large clinical cohort', Journal of Clinical Epidemiology, 100, pp. 82 - 91, http://dx.doi.org/10.1016/j.jclinepi.2018.04.015

Edmiston N; Petoumenos K; Smith DJ, 2018, 'Multimorbidity, not human immunodeficiency virus (HIV) markers predicts unplanned admission among people with HIV in regional New South Wales', Internal Medicine Journal, 48, pp. 706 - 713, http://dx.doi.org/10.1111/imj.13733

McMahon CN; Petoumenos K; Hesse K; Carr A; Cooper DA; Samaras K, 2018, 'High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years', AIDS, 32, pp. 451 - 459, http://dx.doi.org/10.1097/QAD.0000000000001709

McMahon CN; Petoumenos K; Hesse K; Carr A; Cooper DA; Samaras K, 2018, 'High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.', AIDS, 32, pp. 451 - 459, http://dx.doi.org/10.1097/QAD.0000000000001709

Gray RT; Watson J; Cogle AJ; Smith DE; Hoy JF; Bastian LA; Finlayson R; Drummond FM; Whittaker B; Law MG; Petoumenos K; Han A, 2018, 'Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive', Sexual Health, 15, pp. 13 - 19, http://dx.doi.org/10.1071/SH16237

Puhr R; Petoumenos K; Youds D; Law MG; Templeton DJ; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Rankin A; Baker D; O'Connor CC; Thackeray O; Jackson E; McCallum K; Ryder N; Sweeney G; Cooper D; Carr A; Macrae K; Hesse K; Finlayson R; Gupta S; Langton-Lockton J; Shakeshaft J; Brown K; Idle S; Arvela N; Varma R; Lu H; Couldwell D; Eswarappa S; Smith DE; Furner V; Cabrera G; Fernando S; Cogle A; Lawrence C; Mulhall B; Boyd M; Law M; Huang R; Han A; Gunathilake M; Payne R; O'Sullivan M; Croydon A; Russell D; Cashman C; Roberts C; Sowden D; Taing K; Marshall P; Orth D; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Allen A; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K, 2017, 'The impact of changes in HIV management guidelines on time to treatment initiation in Australia', HIV Medicine, 18, pp. 701 - 703, http://dx.doi.org/10.1111/hiv.12504

Petoumenos K; Huang R; Hoy J; Bloch M; Templeton DJ; Baker D; Giles M; Law MG; Cooper DA; Han A, 2017, 'Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years - The Australian Positive & Peers Longevity Evaluation Study (APPLES)', PLoS ONE, 12, pp. e0184583, http://dx.doi.org/10.1371/journal.pone.0184583

Jin F; Roberts JM; Grulich AE; Poynten IM; MacHalek DA; Cornall A; Phillips S; Ekman D; McDonald RL; Hillman RJ; Templeton DJ; Farnsworth A; Garland SM; Fairley CK; Tabrizi SN; Law C; Biro C; Richards A; Thurloe J; Adams M; McCaffery K; Howard K; Kelly P; Seeds D; Garcia M; Carr A; Feeney L; Gluyas R; Prestage G; Petoumenos K; Law M; Acraman B; McGrath P; Mellor R; Pezzopane P, 2017, 'The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men', AIDS, 31, pp. 1303 - 1311, http://dx.doi.org/10.1097/QAD.0000000000001462

Martinello M; Grebely J; Petoumenos K; Gane E; Hellard M; Shaw D; Sasadeusz J; Applegate TL; Dore GJ; Matthews GV, 2017, 'HCV reinfection incidence among individuals treated for recent infection', Journal of Viral Hepatitis, 24, pp. 359 - 370, http://dx.doi.org/10.1111/jvh.12666

Petoumenos K; Choi JY; Hoy J; Kiertiburanakul S; Ng OT; Boyd M; Rajasuriar R; Law M; Han A, 2017, 'CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy', Antiviral Therapy, 22, pp. 659 - 668, http://dx.doi.org/10.3851/IMP3155

Templeton DJ; Roberts JM; Poynten IM; Law C; Hillman RJ; Farnsworth A; Fairley CK; Tabrizi SN; Garland SM; Grulich AE; Jin F; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley K; Feeney L; Fraissard E; Howard K; Law M; MacHalek D; McCaffery K; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2017, 'Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: Baseline findings from the Study of the Prevention of Anal Cancer (SPANC)', European Journal of Cancer Prevention, 26, pp. 212 - 216, http://dx.doi.org/10.1097/CEJ.0000000000000321

Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Petoumenos K; Zablotska IB; Poynten IM; Mao L; Law MG; Amin J; Han A, 2016, 'Hospitalization for anxiety and mood disorders in HIV-infected and -uninfected gay and bisexual men', Journal of Acquired Immune Deficiency Syndromes, 73, pp. 589 - 597, http://dx.doi.org/10.1097/QAI.0000000000001147

Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Petoumenos K; Zablotska IB; Poynten IM; Mao L; Law MG; Amin J, 2016, 'Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.', J Acquir Immune Defic Syndr, 73, pp. 589 - 597, http://dx.doi.org/10.1097/QAI.0000000000001147

Callander D; Stoové M; Carr A; Hoy JF; Petoumenos K; Hellard M; Elliot J; Templeton DJ; Liaw S; Wilson DP; Grulich A; Cooper DA; Pedrana A; Donovan B; McMahon J; Prestage G; Holt M; Fairley CK; McKellar-Stewart N; Ruth S; Asselin J; Keen P; Cooper C; Allan B; Kaldor JM; Guy R; Cooper D; Liaw T, 2016, 'A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: The Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol', BMC Infectious Diseases, 16, pp. 752, http://dx.doi.org/10.1186/s12879-016-2073-2

Machalek DA; Jin F; Poynten IM; Hillman RJ; Templeton DJ; Law C; Roberts JM; Tabrizi SN; Garland SM; Farnsworth A; Fairley CK; Grulich AE; Acraman B; Adams M; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Ekman D; Feeney L; Fraissard E; Howard K; Law M; McCaffery K; McDonald R; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2016, 'Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men', Papillomavirus Research, 2, pp. 97 - 105, http://dx.doi.org/10.1016/j.pvr.2016.05.003

Martinello M; Gane E; Hellard M; Sasadeusz J; Shaw D; Petoumenos K; Applegate T; Grebely J; Maire L; Marks P; Dore GJ; Matthews GV; Cooper D, 2016, 'Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study', Hepatology, 64, pp. 1911 - 1921, http://dx.doi.org/10.1002/hep.28844

Moore CL; Gidding HF; Jin F; Mao L; Petoumenos K; Zablotska IB; Poynten IM; Prestage G; Law MG; Grulich AE; Amin J; Han A, 2016, 'Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men', AIDS and Behavior, 20, pp. 2372 - 2386, http://dx.doi.org/10.1007/s10461-016-1303-3

Mulhall BP; Wright ST; De La Mata N; Allen D; Brown K; Dickson B; Grotowski M; Jackson E; Petoumenos K; Foster R; Read T; Russell D; Smith DJ; Templeton DJ; Fairley CK; Law MG, 2016, 'Risk factors associated with incident sexually transmitted infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study', HIV Medicine, 17, pp. 623 - 630, http://dx.doi.org/10.1111/hiv.12371

Petoumenos K; Law MG, 2016, 'Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons', Current Opinion in HIV and AIDS, 11, pp. 514 - 520, http://dx.doi.org/10.1097/COH.0000000000000306

Roberts JM; Jin F; Thurloe JK; Ekman D; Adams MK; McDonald RL; Biro C; Poynten IM; Grulich AE; Farnsworth A; Aarnsworth R; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley C; Farnsworth A; Feeney L; Garcia M; Garland S; Gluyas R; Hillman R; Howard K; Lawa F; Law C; Law M; Machalek D; McCaffery K; McGrath P; Mellor R; Pendlebury S; Petoumenos K; Pezzopane P; Phillips S; Mary Poynten I; Prestage G; Richards A; Seeds D; Segelov E; Tabrizi S; Templeton D; Tong W; Varma R, 2016, 'The value of a transformation zone component in anal cytology to detect HSIL', Cancer Cytopathology, 124, pp. 596 - 601, http://dx.doi.org/10.1002/cncy.21730

Machalek DA; Poynten IM; Jin F; Hillman RJ; Templeton DJ; Law C; Roberts JM; Tabrizi SN; Garland SM; Farnsworth A; Fairley CK; Grulich AE; Acraman B; Adams M; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Ekman D; Fairley K; Feeney L; Fraissard E; Howard K; Law M; McCaffery K; McDonald R; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2016, 'A composite cytology-histology endpoint allows a more accurate estimate of anal high-grade squamous intraepithelial lesion prevalence', Cancer Epidemiology Biomarkers and Prevention, 25, pp. 1134 - 1143, http://dx.doi.org/10.1158/1055-9965.EPI-15-1106

Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Mao L; Petoumenos K; Zablotska IB; Poynten IM; Law MG; Amin J; Han A, 2016, 'Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men', HIV Medicine, 17, pp. 327 - 339, http://dx.doi.org/10.1111/hiv.12312

Kovari H; Sabin CA; Ledergerber B; Ryom L; Reiss P; Law M; Pradier C; Dabis F; d'Arminio Monforte A; Smith C; de Wit S; Kirk O; Lundgren JD; Weber R, 2016, 'Antiretroviral drugs and risk of chronic alanine aminotransferase elevation in human immunodeficiency virus (HIV)-monoinfected persons: The data collection on adverse events of Anti-HIV drugs study', Open Forum Infectious Diseases, 3, http://dx.doi.org/10.1093/ofid/ofw009

Giles ML; Zapata MC; Wright ST; Petoumenos K; Grotowski M; Broom J; Law MG; O'Connor CC, 2016, 'How do outcomes compare between women and men living with HIV in Australia? An observational study', Sexual Health, 13, pp. 155 - 161, http://dx.doi.org/10.1071/SH15124

Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2016, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies', ANTIVIRAL THERAPY, 21, pp. 425 - 434, http://dx.doi.org/10.3851/IMP3035

Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2016, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies', Antiviral therapy, 21, pp. 465, http://dx.doi.org/10.3851/IMP3073

Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P; Acraman B, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003

Templeton DJ; Wright ST; McManus H; Lawrence C; Russell DB; Law MG; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Allardice K; Baker D; Odgers E; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Ryder N; Taylor S; Cooper D; Carr A; Lee F; McRae K; Hesse K; Finlayson R; Gupta S; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Arvela N; Wray L; Thng C; Foster R; Lu H; Couldwell D; DSmith E; Furner V; Fernando S; Dubbo ; Watson J; Mulhall B; Wright S; Bendall C; Boyd M; Gunathilake M; Payne R; O'Sullivan M; White S; Russell D; Joslin J; Cashman C; Sowden D; Taing K; McGill K; Orth D; Youds D; Kelly M; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; NRoth J; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K; Morwood K; Roth N; Choong K; Cooper D; Han A, 2015, 'Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)', BMC Infectious Diseases, 15, pp. 326, http://dx.doi.org/10.1186/s12879-015-1051-4

De La Mata N; Mao L; De Wit J; Smith D; Holt M; Prestage G; Wilson DP; Petoumenos K, 2015, 'Estimating antiretroviral treatment coverage rates and viral suppression rates for homosexual men in Australia', Sexual Health, 12, pp. 453 - 457, http://dx.doi.org/10.1071/SH15037

Petoumenos K; Law M; Han A, 2015, 'HIV-infection and comorbidities: A complex mix', The Lancet HIV, 2, pp. e265 - e266, http://dx.doi.org/10.1016/S2352-3018(15)00082-X

Wright ST; Law MG; Cooper DA; Keen P; McDonald A; Middleton M; Woolley I; Kelly M; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Little JL; Smith D; Mincham C; Baker D; Ieroklis V; Templeton DJ; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Taylor S; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Patel A; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Fernando S; Chuah J; Watson J; Lawrence C; Mulhall B; McManus H; Bendall C; Boyd M; Ryder N; Payne R; Russell D; Doyle-Adams S; Sowden D; Taing K; McGill K; Orth D; Youds D; Gibson A; Magon H; Dickson B; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Giles M; Hoy J; Williams J; Nolan D; Robinson J; Morwood K; Roth N; Choong K; Li PCK; Lee MP; Vanar S; Faridah S; Kamarulzaman A; Choi JY; Vannary B; Ditangco R; Tsukada K; Pujari S; Makane A; Ng OT; Sasisopin AJ; Han A, 2015, 'Temporal trends of time to antiretroviral treatment initiation, interruption and modification: Examination of patients diagnosed with advanced HIV in Australia', Journal of the International AIDS Society, 18, pp. 19463, http://dx.doi.org/10.7448/IAS.18.1.19463

Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Kamara DA; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J; Finlayson R; Cooper D; Carr A; Bloch M; Harrod M; Pett S; Petoumenos K; Gold J; Medland N; Sullivan J; Han A, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, 12, pp. e1001809, http://dx.doi.org/10.1371/journal.pmed.1001809

Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; Ellis D; Bloch M; Franic T; Agrawal S; McCann L; Cunningham N; Vincent T; Allen D; Little JL; Smith D; Gray C; Baker D; Vale R; Templeton DJ; Dijanosic C; Jackson E; McCallum K; Taylor S; Cooper D; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Shakeshaft J; Brown K; McGrath C; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Watson J; Lawrence C; Mulhall B; Law M; Petoumenos K; McManus H; Bendall C; Boyd M; Kulatunga A; Knibbs P; Chuah J; Ngieng M; Dickson B; Russell D; Downing S; Sowden D; Broom J; Taing K; Johnston C; McGill K; Orth D; Youds D; Kelly M; Gibson A; Magon H; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Nicolson J; Lau H; Read T; Silvers J; Zeng W; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Skett J; Robinson J; Mean CV; Saphonn V; Vohith K; Zhang FJ; Li PCK; Lee MP; Kumarasamy N; Saghayam S; Ezhilarasi C; Pujari S, 2015, 'HIV and aging: Insights from the Asia Pacific HIV Observational Database (APHOD)', HIV Medicine, 16, pp. 152 - 160, http://dx.doi.org/10.1111/hiv.12188

Winston A; Puls R; Kerr SJ; Duncombe C; Li P; Gill JM; Ramautarsing R; Taylor-Robinson SD; Emery S; Cooper DA; Belloso W; Gazzard B; Hung CC; Jessen H; Kamrulazaman A; Li L; Losso M; Sierra-Madero J; Mallon P; Mason B; Molina JM; Petoumenos K; Phanuphak P; Pollack S; Rooney J; Walmsley S; Wolff M, 2015, 'Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART', PLoS ONE, 10, pp. e0118608, http://dx.doi.org/10.1371/journal.pone.0118608

Petoumenos K; Watson J; Whittaker B; Hoy J; Smith D; Bastian L; Finlayson R; Sloane A; Wright ST; McManus H; Law MG; Han A, 2015, 'Subsidized optimal ART for HIV-positive temporary residents of Australia improves virological outcomes: Results from the Australian HIV Observational Database Temporary Residents Access Study', Journal of the International AIDS Society, 18, pp. 19392, http://dx.doi.org/10.7448/IAS.18.1.19392

Tong WWY; Shepherd K; Garland S; Meagher A; Templeton DJ; Fairley CK; Jin F; Poynten IM; Zaunders J; Hillman RJ; Grulich AE; Kelleher AD; Carr A; Acraman B; Fraissard E; Law C; McGrath P; Mellor R; Norris R; O'Dwyer M; Seeds D; Thompson K; Varma R; Adams M; Biro C; Cornall A; Crampton L; Ekman D; Ellard J; Farnsworth A; Feeney L; Howard K; Hyne S; Law M; Machalek D; McCaffery K; McDonald R; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Roberts J; Schema L; Segelov E; Tabrizi S; Thurloe J; Bailey M; Cunningham P; Fsadni B; Grassi K; Ip S; Lograsso M; McBride K; Merlin K; Munier M-L; Piperias M; Xu Y, 2015, 'Human Papillomavirus 16-Specific T-Cell Responses and Spontaneous Regression of Anal High-Grade Squamous Intraepithelial Lesions', Journal of Infectious Diseases, 211, pp. 405 - 415, http://dx.doi.org/10.1093/infdis/jiu461

Back to profile page